The company was incorporated in the People's Republic of China (“PRC”) on 15 March 2013 as a limited liability company. On 21 July 2021, the Company was converted into a joint stock company with limited liability under the Company Law of PRC.
The Company and its subsidiaries was a medical device company with a main focus on the field of cryoablation minimally-invasive interventional treatment. Based on the Group's liquid nitrogen cryoablation technology, it mainly engages in research and development of cardiovascular innovation minimally invasive based on the cryomedical technology and other related medical products.
总部
Room 1901, 19/F, Lee Garden One, 33 Hysan Avenue, Hong Kong
香港; 香港;
联系方式: 购买Cryofocus Medtech (Shanghai) Co. Ltd.报告以查看信息。
EMIS公司简介是一个更大的信息服务的一部分,它结合了公司,行业和国家数据和分析在超过125个新兴市场.
请求EMIS服务的演示查看更多信息, 申请试用